SUMMARY
Modern anaesthetists rely on the intravenous route for administration of drugs and fluids. This paper traces the development of intravenous equipment from the first, tentative experiments with the intravenous route through to the first intravenous cannulas.
Modern anaesthetists start the day drawing up drugs into syringes and would not consider giving an anaesthetic without intravenous access. Yet early anaesthetists did not have the knowledge, the drugs or the equipment to utilize this route: they did not even imagine it as a possibility.
Ancient primitive man was well aware that blood was essential for life. This led them to believe that the soul resided there and many mythical properties were consequently assigned to blood. The Romans drank the blood of recently slain gladiators in order to acquire their strength. In 1492, Pope Innocent VIII reportedly drank the blood of three young boys in order to rejuvenate him. These were dangerous times. In the late 1500s, a Spanish doctor, Michael Servetus concluded that blood was oxygenated in the lungs. Unfortunately he published this along with his belief that the Holy Trinity did not exist-a seemingly unrelated but extremely heretical belief. For these transgressions he was burned at the stake with green wood to prolong his execution. Little wonder that no interest was shown in the circulation until the following century. In 1628 William Harvey published his famous essay describing the flow of blood throughout the body. Initially he too suffered as a result; his practice declined and he was ostracized by the profession. However, as the physician to James I and Charles I, he had the benefit of royal patronage and, by the time of his death twenty years later, he had seen his work recognized throughout the world's universities. Just in time, as his royal patron was about to lose his head and Britain to lose its monarchy for a brief dabble with republicanism under Oliver Cromwell.
As science became a little more acceptable, scientists became more adventurous and some began to experiment with intravenous injections into animals. Many seem to have experimented but few kept good records. The best-documented experiments were performed by Christopher Wren, who is best remembered today for his architecture, but he was originally a scientist and astronomer being appointed the Professor of Astronomy at Gresham College in London at the age of 25. A small group of scholars had gathered there who were eventually to form the Royal Society under the patronage of Charles II of England in 1662. They included Sir Christopher Wren and Robert Boyle (of Boyle's Law fame). It is not clear why Wren began experimenting with intravenous injections but his interests were extremely diverse, encompassing everything from telescopes to submarines. In 1656, he conducted a series of experiments administering intravenous substances to dogs. The experiments were conducted using an animal bladder attached to a hollow goose quill inserted into a large vein. He injected opium, alcohol and Crocus metallorum (a seventeenth century emetic) into different dogs. As we would expect, the first went to sleep, the second became very drunk and the third became very dead. His aim was to study whether substances given orally could also be given intravenously with the same effect. Having established that they could, he ceased his experiments. He seems to have been unaware of the anaesthetic implications of his research or, at least, unwilling to pursue them.
Others followed. Daniel Major, Professor of Medicine in Kiel and J. Sigismund Elsholtz of Brandenburg injected opium into animals and human volunteers in 1662 and 1665 respectively. Elsholtz concluded that there were therapeutic indications for intravenous therapy but did not pursue it further. He was many years ahead of his time and it was almost two hundred years before intravenous analgesia and anaesthesia were studied again.
Part of the problem was a lack of convenient equipment. Work began on suitable equipment in the mid 1850s; the hollow needle and the syringe were both developed around the same time but not for intravenous use. As intravenous therapy developed over the next few decades, the intravenous cannula was developed out of necessity.
But first the needle and syringe. Francis Rynd, a Dublin surgeon, conducted research into neuralgia using an eye-dropper and spring-loaded trochar and cannula in 1845. He is often credited with the perfection of the hollow needle, but he did not publish his paper until 1861 and his was not a simple hollow needle. Alexander Wood of Edinburgh published his research into the subcutaneous needle in 1855; Fordyce Barker introduced the needle into the United States a year later. Since these developments were concomitant with the development of the syringe it is perhaps academic to consider them separately.
Syringes utilizing compressed bulbs had been available in crude form since the time of Hippocrates in the fifth century BC. They were constructed of animal bladders and pipes or quills and used for irrigation or enemas. A piston and barrel syringe was described about 180 BC by Heron of Alexandria and used to aspirate pus from wounds. Little is then known about piston and barrel syringes until the sixteenth century, when metal syringes became standard medical equipment for irrigation of wounds and fistulae and aspiration of pus.
The French physician, Charles Gabriel Pravaz is widely but erroneously credited with the invention of the syringe and subcutaneous medication. His experiments, which were conducted shortly before his death, involved the use of a silver metal syringe and injection of perchloride of mercury via a trochar into arterial aneurysms in sheep. The syringe was an advance on other opaque devices, as it contained a screw mechanism, which enabled the operator to estimate dosage.
Credit for the perfection of the glass syringe must go to Alexander Wood. In 1855 Wood described the use of a glass syringe and needle to inject subcutaneous morphine into the region of peripheral Over the years the syringe was modified, adding graduations and decreasing the size of the needle. While we may credit Alexander Wood with the development of the glass syringe, he used the device solely for subcutaneous medication. He appears to have been aware of the systemic effects of his medication, but only concerned with the local effects on nerves. Charles Hunter, a London surgeon, coined the term "hypodermic" and believed that the injected medication was effective due to its systemic action.
He was embroiled in a lengthy dispute about priority with Alexander Wood and others but did not publish his findings until 1858. Wood's treatment of neuralgia by subcutaneous injection rapidly became popular in England. His syringes were advertised as "Dr Alexander Wood's narcotic injection syringes" available from Archibald Young, Queen's Cutler in Edinburgh. L. J. Béhier described the treatment in Paris in 1859 and was responsible for popularizing it in Europe. He rejected the Ferguson Wood syringe in favour of the metal Pravaz syringe, and utilizing its screw piston to provide some estimation of dose. Béhier recommended using a small cannula with a capacity of four drops. Five quarter turns were required to deliver one drop into the tissues, with a pause after each drop to ensure accuracy. A trochar and cannula were inserted into the tissues and the trochar withdrawn before attaching the syringe to the cannula. Given the drawn-out nature of this treatment, it is not surprising that many patients never returned and were presumed "probably cured". Most of his patients suffered from sciatica and were injected with subcutaneous atropine. A few others with paralysis were treated with strychnine sulphate. Alexander Wood apparently used strychnine only once: "One remarkable case, many years ago, I cured by applying nux vomica to the blistered surface; but I never tried it again, for it seemed likely to kill two people: my patient, an old lady, who nearly died of the poison; and myself, then a young doctor, who nearly died of fright."
Béhier's complicated trochar and cannula equipment was manufactured in Paris by the instrument maker, Charrière, but was eventually replaced by a syringe with hollow needle attached. The screw piston was maintained. Another Parisian instrument maker, Mathieu, developed the "seringue decimale hypodermique" which featured a bayonet catch to allow either a piston or screw action. The screw action once again allowed estimation of dose.
Luer, the third of the Parisian instrument makers, is better known to modern anaesthetists and many of his modifications survive to this day. He utilized a piston barrel and dispensed with the screw action for attaching the needle. His simple conical nozzle, or push fitting, is the most common syringe fitting currently in use.
The Luer syringe became the standard syringe until the introduction of the Record syringe, made in Berlin by Dewitt and Herz around about 1906. This metal and glass syringe contained some technical improvements on the Luer syringe. The piston and barrel construction was more precise, the piston was fitted with a concentric slip ring and the metal attachments were soldered to the glass by a special alloy. The piston fitted tightly but did not require lubricants and the barrel could be emptied to the last drop. Both syringes continued in popular usage for the next fifty years. Unfortunately though, the fittings on the Record syringe were a different size from the Luer fittings and this caused much confusion. Adapters were made but were coveted and frequently lost. Finding the carefully inserted needle did not fit the syringe caused a great deal of frustration.
The all-glass syringe was developed about 1896 but was not widely used. In 1945 the British Medical Research Council recommended the use of all-glass type syringes due to problems sterilizing the metal/ glass syringes. Eventually in the 1960s disposable syringes were introduced with standard Luer fittings thus resolving the problems of sterility and mismatching fittings.
Administration of drugs and fluid by the intravenous route grew in popularity from the turn of the century. But securing intravenous access was something of an ordeal. The following description appeared in the Lancet in 1911. "Dr. J. J.Watson has described an ingenious method by which he has seldom failed to enter the vein on the ��rst attempt. If the vein is small or the patient is fat, a ligature is applied above the elbow. A medium-sized sewing needle is passed through the skin and upper quadrant of the vein and anchors the vein to the skin. The artery forceps or needle holder used to insert the needle is taken off and clamped on the point side of the needle about a quarter of an inch from the vein. The forceps is gently lifted with the left hand, thus elevating the upper wall of the vein with the skin. With the right hand the injection needle is introduced into the vein almost parallel with its axis."
Initially cannulas were designed for short-term use and were not suitable for repeated administration. One of the earliest such needles was the Strauss cannula which was designed in 1907 by Hermann Strauss. It had a rounded plate on the end for gripping and was intended to be easily manufactured by any instrument maker, a feature not often sought by modern manufacturers. It was very popular and remained in use long after the death of its designer in a German concentration camp. In German-speaking countries, needles with a gripping plate are still referred to as Strauss cannulas.
Heparin was introduced in the late 1930s for the prevention of deep vein thrombosis, the treatment requiring four-hourly intravenous injections. The problems associated with this delivery led to the search for an indwelling intravenous cannula. Thore Olovson, a surgeon at St. Görans Hospital sought help from Meyer, an instrument maker at Stille-Werner in Stockholm. Together they devised a special needle for repeat injections. This needle had a wing at the head to allow it to be secured to the skin. From this point it was bent at right-angles to ��nish in a ring screw. A removable rubber membrane was then screwed into the ring. Heparin injections were made through the rubber membrane using a ��ne needle. This needle was ��rst described in "Der Chirurg" in 1940 as a "Heparine needle".
Torsten Gordh trained as anaesthetist in U.S.A. with Ralph Waters and returned to Sweden in 1940 to become the ��rst anaesthetist in that country. Gordh was shown the Olovson needle by Meyer and rapidly adapted it for intravenous anaesthesia. He described the adapted needle in Anesthesiology in 1945 and from then on the needle was often referred to as the "Gordh needle". His modi��cations involved joining a conical connector to the proximal end so that it could be attached to an intravenous infusion. This could be capped off when the needle was only required for intermittent injections. A ��ne needle was required to administer injections and the membrane could apparently be used 200 times. The needle was taken apart for sterilization. It was an extremely popular needle but the membrane did leak when used too often which allowed blood to flow back and clot in the needle. Needles puncturing the membrane also soon became blunt.
Other cannulas followed the Gordh-Olovson. The Austrian Domanig needle, designed in 1950 by a surgeon, Erwin Domanig and an anaesthetist, Volkmar Feurstein became popular for blood transfusions. It, too, had a rubber membrane but had two detachable connectors to allow two infusions to be given at once. It also had a sharp cannula for venepuncture within an outer blunt cannula. However it was not often used for long-term therapy as it was associated with injury. James Mitchell, an anaesthetist in Oxford, designed a more complicated cannula in 1952 with the help of Mr Richard Salt. It was one of the earliest self-sealing cannulas and had quite a complex design. The tip of the needle was solid and the ori��ce was 1cm from the end. Hinged to the needle was an external light metal plate with a soft rubber pad. The needle was inserted C. Ball by attaching a fluid-��lled syringe and swinging the plate to one side. Once position was con��rmed in the vein, the syringe was withdrawn and the plate swung over the needle. The rubber pad would then press the skin and vein wall against the ori��ce. Saline injected via a syringe would overcome the resistance but there was no flash back when the syringe was withdrawn. The plate could be swung aside to allow intravenous infusions. In retrospect, the plate spring appears cumbersome but the cannula was extremely popular.
Obviously there were many other steps along the way to the equipment we use today, but these were the early beginnings of skills and equipment which are now indispensable.
